Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome
2003
Stroke rehabilitation
2011 Standout
No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled "add on" trial.
2004
Differential diagnosis and evaluation in pediatric multiple sclerosis
2007
Transcranial Magnetic Stimulation in Clinical Psychiatry
2006
IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome
1998
Genetic and environmental risk factors for idiopathic inflammatory myopathies
2002
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
2008
Inhibitory influence of the ipsilateral motor cortex on responses to stimulation of the human cortex and pyramidal tract
1998
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
2003
ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity
2001
Cerebrovascular disorders in patients with diabetes mellitus
1996
Risk Factors for Ischaemic Stroke
2008
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies
2013
Glucose Modulation of Ischemic Brain Injury: Review and Clinical Recommendations
1996
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
The neuropoietic cytokine family in development, plasticity, disease and injury
2007
Modulation of motor cortex excitability in the left hemisphere during action observation: a single- and paired-pulse transcranial magnetic stimulation study of self- and non-self-action observation
2003
Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy
2014
Neurophysiological mechanisms underlying the understanding and imitation of action
2001 Standout
Lesion distribution in children with clinically isolated syndromes
2008
Guillain-Barré syndrome
2016 Standout
Central fatigue assessed by transcranial magnetic stimulation
1996
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
2004 Standout
Paraneoplastic Gastrointestinal Motor Dysfunction: Clinical and Laboratory Characteristics
2001
Pediatric Multiple Sclerosis
2010
The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome
2002
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Guillain–Barré Syndrome
2012 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Amyotrophic lateral sclerosis
2011 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Body tempreture correlates with functional outcome and lesion size of cerebral infarction
2009
Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
2003
Pediatric Multiple Sclerosis
2011
The Natural History of Recurrent Optic Neuritis
2004
Early Electrodiagnostic Findings in Guillain-Barré Syndrome
2001
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
2006
Acute Care in Stroke: The Importance of Early Intervention to Achieve Better Brain Protection
2003
Regional homogeneity approach to fMRI data analysis
2004 Standout
Dynamic changes in corticospinal excitability during motor imagery
1999
Effect of fatiguing maximal voluntary contraction on excitatory and inhibitory responses elicited by transcranial magnetic motor cortex stimulation
1996
Neural Simulation of Action: A Unifying Mechanism for Motor Cognition
2001 Standout
Review: An update on inflammatory and autoimmune myopathies
2010
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
2006
Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke
2005
Diabetes and Atherosclerosis
2002 Standout
Small fiber neuropathy in Fabry disease
2012
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
2002 Standout
Theta Burst Stimulation of the Human Motor Cortex
2005 Standout
Comparative Sensitivity of Computed Tomography vs. Magnetic Resonance Imaging for Detecting Acute Posterior Fossa Infarct
2012
What Disconnection Tells about Motor Imagery: Evidence from Paraplegic Patients
2004
Genomic Analysis of Reactive Astrogliosis
2012 Standout
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
2008
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Long-lasting depression of motor-evoked potentials to transcranial magnetic stimulation following exercise
1995
Update on the genetics of the idiopathic inflammatory myopathies
2000
Neurological manifestations in Fabry's disease
2007
Circulating tumor necrosis factor‐α correlates with electrodiagnostic abnormalities in Guillain‐Barré syndrome
1997
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Value of early variables as predictors of short-term outcome in patients with acute focal cerebral ischemia
1996
Major Depressive Disorder
2008 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
HOSPITAL MANAGEMENT OF DIABETES
2000
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study
1997
Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke
2003
Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size
2002
Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy
2004
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Action recognition in the premotor cortex
1996 Standout
Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes
2010
Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study
2002
Polymyositis and dermatomyositis
2003 Standout
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions
2007
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Guillain-Barré syndrome
2005 Standout
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Management of Diabetes and Hyperglycemia in Hospitals
2004
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control
2004
Inflammatory Muscle Diseases
2015 Standout
Editorial Expression of Concern for multiple articles
2008 StandoutNobel
THE MIRROR-NEURON SYSTEM
2004 Standout
Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis
2012
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
2006
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke
2002
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage
2003
Diabetes, the Metabolic Syndrome, and Ischemic Stroke
2007
Stroke in patients with diabetes. The Copenhagen Stroke Study.
1994
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
2002
Motor Facilitation While Observing Hand Actions: Specificity of the Effect and Role of Observer's Orientation
2002
Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients
2001 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Motor facilitation during action observation: a magnetic stimulation study
1995 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Acute blood glucose level and outcome from ischemic stroke
1999
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Functional MRI cerebral activation and deactivation during finger movement
2000
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
2007
Fever in Acute Stroke Worsens Prognosis
1995
Hyperglycemia during Ischemia Rapidly Accelerates Brain Damage in Stroke Patients Treated with tPA
2007
Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke
2003
Hyperglycemia in the acute phase of stroke is not caused by stress.
1993
Works of Lynette Kiers being referenced
Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype
2009
Quantitative studies of F responses in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1994
Variability of motor potentials evoked by transcranial magnetic stimulation
1993
MAGNETIC RESONANCE IMAGING IN POSTERIOR CIRCULATION INFARCTION: IMPACT ON DIAGNOSIS AND MANAGEMENT
1989
Clinical features of Fabry's disease in Australian patients
2002
Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis
2012
Assessment of cortical motor output: compound muscle action potential versus twitch force recording
1995
Neurology of Fabry disease
2007
Paraneoplastic Anti-Neuronal Nuclear IgG Autoantibodies (Type I) Localize Antigen in Small Cell Lung Carcinoma
1991
Facilitatory effect of thinking about movement on magnetic motor-evoked potentials
1997
Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex
1999
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms
2013
Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy
1994
High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes
2012
Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy
1994
Crossed inhibition in the human motor system.
1995
Risk factors for developing multiple sclerosis after childhood optic neuritis
1997
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2005
Stroke topography and outcome in relation to hyperglycaemia and diabetes.
1992